Biogen BIIB
NASDAQ BIIB
$222.82 -3.06 (-1.35%)
At close: Oct 1, 2026 · 4:00 PM EDT

Biogen (BIIB) Total Non-Current Liabilities (2009 - 2026)

Updated

Biogen (BIIB) reported Total Non-Current Liabilities of $12.42 billion for Q2 2026, up 25.5% from $9.9 billion a year earlier and up 23.6% from the prior quarter.

Analysis

Biogen (BIIB) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Biogen posted Total Non-Current Liabilities of $10.43 billion, down 1.6% from FY2024.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of -3.7% (FY2020 to FY2025).
  • By year, Total Non-Current Liabilities came in at $10.6 billion in FY2024 (-5.9%), $11.26 billion in FY2023 (+10.2%), $10.22 billion in FY2022 (-11.9%) and $11.6 billion in FY2021 (-8.0%).
  • The Q2 2026 figure ranks as the highest quarterly Total Non-Current Liabilities since Q3 2023.
  • Year over year, Total Non-Current Liabilities gained in 1 of the last eight quarters, with an average decline of 1.7%.
  • The high point for year-over-year Total Non-Current Liabilities in five years was Q2 2026 (growth of 25.5%); the low point was Q2 2023 (a decline of 17.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $10.04 billion (Q1 2026), $10.43 billion (Q4 2025) and $10.24 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Biogen 33.37 Bn 20.03 Bn 1.96 Bn 12.42 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.42 Bn
Mar 31, 2026 10.04 Bn
Dec 31, 2025 10.43 Bn
Sep 30, 2025 10.24 Bn
Jun 30, 2025 9.90 Bn
Mar 31, 2025 10.30 Bn
Dec 31, 2024 10.60 Bn
Sep 30, 2024 11.21 Bn
Jun 30, 2024 10.36 Bn
Mar 31, 2024 10.58 Bn
Dec 31, 2023 11.26 Bn
Sep 30, 2023 12.97 Bn
Jun 30, 2023 9.92 Bn
Mar 31, 2023 9.88 Bn
Dec 31, 2022 10.22 Bn
Sep 30, 2022 10.89 Bn
Jun 30, 2022 12.05 Bn
Mar 31, 2022 11.11 Bn
Dec 31, 2021 11.60 Bn
Sep 30, 2021 11.61 Bn
API Access

Biogen Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BIIB&period=max&api_key=YOUR_API_KEY